03 November 2020>: Clinical Research
Chromogranin A: A Valuable Serum Diagnostic Marker for Non-Insulinoma Neuroendocrine Tumors of the Pancreas in a Chinese Population
Liwen Hong 1AE* , Yuan Wang 2BD* , Tianyu Zhang 1CF , Chen Zhang 1BC , Lei Wang 1AD , Liying Wang 3EG* , Zhengting Wang 1AG* , Jie Zhong 1AGDOI: 10.12659/MSM.926635
Med Sci Monit 2020; 26:e926635
Table 1 Demographic and pathological characteristics of patients with P-NETs.
Demographic and pathological features | Number n=73 | |
---|---|---|
Gender | Male | 29 (39.7%) |
Age (years) at diagnosis | Median (range) | 49 (16–75) |
P-NENs subtype | Insulinoma | 43 (58.9%) |
Non-insulinoma P-NENs | 30 (41.1%) | |
NF* | 29 | |
Gastrinoma | 1 | |
Surgery or not | Curative surgery | 61 (83.6%) |
Non-resection | 12 (16.4%) | |
Liver metastasis or not | No | 61 (83.6%) |
Yes | 12 (16.4%) | |
Grade | G1 | 45 (61.6%) |
G2 | 20 (27.4%) | |
G3 | 8 (11.0%) | |
Stage | I | 45 (61.6%) |
II | 16 (21.9%) | |
III | 0 | |
IV | 12 (16.4%) | |
* NF – non-functional tumor. |